Disease

Lymphoma

Biology

Internal medicine

Oncology

Paleontology

Dermatology

Cutaneous T-cell lymphoma

Medicine

T-cell lymphoma

Mycosis fungoides

Chemotherapy

Stage (stratigraphy)

Lymphoproliferative disorders

American Journal of Hematology

Cutaneous T-cell lymphomas are a heterogenous group of T-cell lymphoproliferative disorders involving the skin, the majority of which may be classified as Mycosis Fungoides (MF) or Sézary Syndrome (SS).The diagnosis of MF or SS requires the integration of clinical and histopathologic data.TNMB (tumor, node, metastasis, blood) staging remains the most important prognostic factor in MF/SS and forms the basis for a "risk-adapted," multi-disciplinary approach to treatment. For patients with disease limited to the skin, expectant management or skin-directed therapies is preferred, as both disease-specific and overall survival for these patients is favorable. In contrast, patients with advanced-stage disease with significant nodal, visceral or blood involvement are generally approached with biologic-response modifiers or histone deacetylase inhibitors prior to escalating therapy to include systemic, single-agent chemotherapy. In highly-selected patients, allogeneic stem-cell transplantation may be considered, as th...

Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management